Evidence map›Paper›PMID 30221066›Full record

ReviewOncoimmunology

Personal history of infections and immunotherapy: Unexpected links and possible therapeutic opportunities.

Camille Jacqueline, Nathalie Bonnefoy, Guillaume M Charrière, Frédéric Thomas, Benjamin Roche

Abstract readReview
In one paragraph

Review in Oncoimmunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Is adaptive therapy natural?PLoS biology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Camille JacquelineCentre for Ecological and Evolutionary Research on Cancer (CREEC), Montpellier, France.
Nathalie BonnefoyIRCM, INSERM, Université de Montpellier, ICM, F-34298, Montpellier, France.
Guillaume M CharrièreIHPE, UMR 5244, CNRS, Ifremer, Université de Perpignan Via Domitia, Université de Montpellier, Montpellier, 34095, France.
Frédéric ThomasCentre for Ecological and Evolutionary Research on Cancer (CREEC), Montpellier, France.
Benjamin RocheCentre for Ecological and Evolutionary Research on Cancer (CREEC), Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent breakthroughs in the understanding of tumor immune biology have given rise to a new generation of immunotherapies, harnessing the immune system to eliminate tumors. As the typology and frequency of encountered infections are susceptible to shape the immune system, it could also impact the efficiency of immunotherapy. In this review, we report evidences for an indirect link between personal history of infection and different strategies of immunotherapy. In the current context of interest rise for personalized medicine, we discuss the potential medical applications of considering personal history of infection to design immunotherapeutic strategies.

Indexed as

Adoptive cell transferCancer vaccineImmune checkpointsImmunotherapyInfectionsPersonalized medicine

Identifiers

PMID30221066
PMCPMC6136881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.